TrialBritish journal of haematology2024

Phase II trial of imatinib mesylate in patients with PDGFRA/B-negative hypereosinophilic syndrome.

Dong Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.